Cite
HARVARD Citation
Sandblom, V. et al. (n.d.). [OA164] Vandetanib may act as a radiosensitiser for 177Lu-octreotate treatment of medullary thyroid cancer. Physica medica. pp. 62-63. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sandblom, V. et al. (n.d.). [OA164] Vandetanib may act as a radiosensitiser for 177Lu-octreotate treatment of medullary thyroid cancer. Physica medica. pp. 62-63. [Online].